A combined biopsy-plugging device based on the Menghini- or Trucut needle for percutaneous liver biopsy: clinical experience.
Impaired blood clotting precludes percutaneous liver biopsy for histologic examination of liver tissue. The transjugular or laparoscopic approach are ways to reduce the risk of bleeding. These techniques, however, are laborious and confined to specialized centers. Methods of plugging the needle track with sealant presented so far are hampered by the need to leave either the cannula in situ or the need for a second percutaneous approach for the application of the sealant. We have tested a combined plugging-biopsy device allowing to perform the biopsy as a one-step procedure in patients with impaired clotting under laparoscopic vision control. In 37 patients either a modified Trucut or Menghini needle was tested. Handling of the Trucut needle proved easier. Tissue yield was satisfactory with both needles. Only one episode of bleeding was observed with a prototype Menghini needle. We conclude, that the combined plugging-biopsy device is a safe and reliable tool for obtaining liver tissue in patients with impaired blood coagulation.
Judmaier
G
G
Department of Internal Medicine, University of Innsbruck, Austria.
Vogel
W
W
Dinges
H P
HP
Zatloukal
K
K
D001707:Biopsy, Needle / Q000295:instrumentation*; D004867:Equipment Design; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D020706:Laparoscopes; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000473:pathology*; D008104:Liver Cirrhosis, Alcoholic / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology* / Q000556:secondary; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000473:pathology
D015718:Fibrin Tissue Adhesive